1049093-89-1 Usage
General Description
2-(2-ethoxyphenyl)acetyl chloride is a chemical compound with the molecular formula C10H11ClO2. It is a derivative of acetyl chloride and contains a benzene ring with an ethoxy group attached to it. The ethoxy group consists of an ethyl group bonded to an oxygen atom. 2-(2-ethoxyphenyl)acetyl chloride is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals, agrochemicals, and dyes. It is also used as a reagent in organic reactions to introduce the acetyl group into other molecules. Additionally, 2-(2-ethoxyphenyl)acetyl chloride is known for its strong irritating odor and should be handled with caution due to its corrosive and toxic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1049093-89-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,9,0,9 and 3 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1049093-89:
(9*1)+(8*0)+(7*4)+(6*9)+(5*0)+(4*9)+(3*3)+(2*8)+(1*9)=161
161 % 10 = 1
So 1049093-89-1 is a valid CAS Registry Number.
1049093-89-1Relevant articles and documents
Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents
Brancaccio, Diego,Cassese, Hilde,Coluccia, Antonio,Di Maro, Salvatore,Giustiniano, Mariateresa,Grassia, Gianluca,Ialenti, Armando,La Pietra, Valeria,La Regina, Giuseppe,Marinelli, Luciana,Martini, Claudia,Novellino, Ettore,Passacantilli, Sara,Silvestri, Romano,Stornaiuolo, Mariano,Taliani, Sabrina
, p. 2135 - 2148 (2015)
The first direct activator of BAX, a pro-apoptotic member of the BCL-2 family, has been recently identified. Herein, a structure-based lead optimization turned out into a small series of analogues, where 8 is the most potent compound published so far. 8 was used as pharmacological tool to ascertain, for the first time, the anticancer potential of BAX direct activators and the obtained results would suggest that BAX direct activators are potential future anticancer drugs rather than venoms.
